Japanese Communications Stock News

Despite announcing strong earnings, Nippon Electric Glass Co., Ltd.'s ( TSE:5214 ) stock was sluggish. We think that...

We wouldn't blame Fast Retailing Co., Ltd. ( TSE:9983 ) shareholders if they were a little worried about the fact that...

A week ago, ORIX Corporation ( TSE:8591 ) came out with a strong set of third-quarter numbers that could potentially...

Mitsubishi Materials (TSE:5711) Q3 2026 earnings snapshot Mitsubishi Materials (TSE:5711) has reported Q3 2026 revenue of ¥454.6b and basic EPS of ¥236.47, backed by net income of ¥30.9b for the quarter. The company’s revenue moved from ¥494.1b in Q3 2025 to ¥454.6b in Q3 2026, while quarterly EPS shifted from ¥187.54 to ¥236.47 over the same period, against a trailing twelve month EPS of ¥162.93 on revenue of ¥1.76t. This combination of a softer top line and firmer per share earnings focuses...

Inpex (TSE:1605) has just wrapped up FY 2025 with fourth quarter revenue of ¥490,704 million and basic EPS of ¥86.17, while trailing twelve month figures sit at ¥2.0 trillion in revenue and EPS of ¥337.94, giving investors a clear view of both the latest quarter and the full year run rate. Over recent periods, revenue has moved from ¥518,280 million and EPS of ¥115.17 in Q4 2024 to ¥490,704 million and EPS of ¥86.17 in Q4 2025, with trailing net profit margin at 19.6% compared with 18.9% a...

Sumitomo Pharma (TSE:4506) is back on investors’ radar after Japan’s Ministry of Health, Labour and Welfare scheduled a February 19 committee review of AMCHEPRY, its allogeneic iPS cell derived therapy for advanced Parkinson’s disease. See our latest analysis for Sumitomo Pharma. The upcoming AMCHEPRY review arrives after a volatile few months, with a 10.81% 7 day share price return and a 14.19% 30 day share price decline. At the same time, a very large 1 year total shareholder return of...

Nissan Motor recently revised its earnings guidance for the fiscal year ending March 31, 2026, now expecting net sales of ¥11,900,000 million, an operating loss of ¥60,000 million and a net loss of ¥650,000 million, largely reflecting faster fixed cost cuts under its Re:Nissan plan and lower foreign exchange headwinds. Although the projected net loss remains very large and is driven mainly by non‑cash restructuring and alignment charges, the sharply reduced operating loss forecast points to...

Organo (TSE:6368) drew investor attention after reporting nine month earnings to December 31, 2025, with sales of ¥127,729 million and net income of ¥17,999 million, alongside fresh full year 2026 earnings guidance. See our latest analysis for Organo. The latest nine month earnings and fresh guidance appear to have caught the market’s attention, with Organo’s 1 day share price return of 2.32% and 7 day share price return of 9.76% contributing to a 1 year total shareholder return of 123.67%...

Why ITOCHU’s new buyback and earnings matter for shareholders ITOCHU (TSE:8001) has put a fresh share repurchase plan and a new earnings update on the table, giving you more detail on how management is handling cash and current profitability. On February 6, 2026, the board approved a buyback of up to 13,000,000 shares, equal to 0.2% of issued share capital, for up to ¥20,000 million, with the program running through March 31, 2026. This sits alongside recently reported nine month results to...

Elliott Investment Management, the largest independent shareholder in Toyota Industries (TSE:6201), has publicly opposed Toyota Fudosan's extended tender offer. The fund argues the offer is significantly undervalued and urges shareholders to reject or withdraw tenders. Only a fraction of shares have reportedly been tendered, highlighting resistance among minority shareholders. The dispute is drawing attention to broader questions around Japanese corporate governance and treatment of minority...

Koito Manufacturing Co., Ltd. recently reported nine‑month results to December 31, 2025, with higher sales of ¥690,005 million but lower net income of ¥23,056 million compared with the prior year. At the same time, the company issued guidance for the fiscal year ending March 31, 2026 that combines an expected decline in net sales with higher operating profit driven by productivity gains, cost reductions, and a global restructuring of its production system. We will now examine how Koito’s...

Kioxia Holdings (TSE:285A) is back in focus after reporting third quarter earnings with higher sales and net income year on year, along with fresh guidance and commentary tied to NAND memory demand. See our latest analysis for Kioxia Holdings. The latest earnings update and guidance arrived alongside very strong recent momentum, with a 1 day share price return of 7.75% and a 30 day share price return of 71.8%. The 1 year total shareholder return is extremely high, suggesting sentiment around...

Tokyo Electron recently announced a share repurchase program of up to 7,500,000 shares for ¥150,000 million and raised its full-year earnings and dividend guidance for the fiscal year ending March 31, 2026. The combination of higher profit and dividend forecasts, alongside a new buyback, signals management’s confidence in cash generation and mid- to long-term profit potential. We’ll now examine how Tokyo Electron’s upgraded earnings outlook and enhanced shareholder returns reshape its...

Rakuten Bank, Ltd. reported past earnings for the nine months ended December 31, 2025, with net interest income rising to ¥102,843 million and net income increasing to ¥53,119 million, driving higher basic and diluted earnings per share year on year. Alongside this strong interim performance, Rakuten Bank raised its full-year earnings forecast while still opting to pay no dividends to prioritize capital retention and business expansion. We will now examine how Rakuten Bank’s upgraded...

Hikari Tsushin (TSE:9435) has just posted its Q3 2026 update, with recent quarterly revenue running at about ¥194.5 billion in Q2 2026 and basic EPS of ¥960.21, against a backdrop where trailing 12 month EPS sat at ¥3,182.21 on revenue of roughly ¥722.5 billion. Over the past reported quarters, the company has seen revenue move from ¥173.0 billion in Q3 2025 to ¥187.7 billion in Q4 2025 and then to ¥194.5 billion in Q2 2026, while quarterly EPS shifted from ¥1,244.00 in Q3 2025 to ¥336.01 in...

In February 2026, Shimadzu Corporation revised its full-year guidance, lifting expected net sales to ¥555,000 million while keeping operating profit and profit attributable to owners of parent unchanged, and simultaneously reported nine-month results showing higher sales and net income than a year earlier. An interesting angle is that Shimadzu attributes the stronger sales outlook mainly to yen depreciation, yet is choosing to reinvest the incremental benefit into M&A, R&D, and other...

As global markets experience volatility driven by mixed economic signals and sector rotations, investors are increasingly seeking stability through dividend stocks. In this dynamic environment, selecting dividend stocks with strong fundamentals and consistent payout histories can offer a reliable income stream while enhancing portfolio resilience.

Lasertec Corporation reported half-year results to December 31, 2025, with sales of ¥128,258 million and net income of ¥45,745 million, alongside announcing a second-quarter dividend increase to ¥132.00 per share from ¥115.00 a year earlier, payable on March 12, 2026. The company also raised its full-year fiscal 2026 guidance, citing earlier customer acceptance of products and a revised yen/US$ exchange rate assumption of ¥145 per US$ compared with ¥135 previously. We will examine how...

What the latest earnings, guidance and dividend signal for investors FUJIFILM Holdings (TSE:4901) has given investors a fresh information set, combining third quarter and nine month earnings, new full year guidance for fiscal 2026, and an affirmed year end dividend outlook. The company reported third quarter sales of ¥857,354 million and net income of ¥73,143 million, alongside nine month sales of ¥2,429,717 million and net income of ¥193,375 million, each higher than the comparable period a...

Why the Myrbetriq legal settlement matters for Astellas shareholders Astellas Pharma (TSE:4503) has just closed its U.S. patent disputes over overactive bladder drug Myrbetriq, securing settlement and upfront licensing payments from Lupin and Zydus, as well as ongoing per unit fees. For you as an investor, this combination of cash inflows and reduced legal uncertainty can influence how you view the earnings profile tied to Myrbetriq and its generic competition in the U.S. market. See our...

It's been a good week for Marui Group Co., Ltd. ( TSE:8252 ) shareholders, because the company has just released its...

Tosoh Corporation's ( TSE:4042 ) investors are due to receive a payment of ¥50.00 per share on 5th of June. This makes...

Investors in TOC Co., Ltd. ( TSE:8841 ) had a good week, as its shares rose 2.5% to close at JP¥867 following the...

The subdued market reaction suggests that Toyota Motor Corporation's ( TSE:7203 ) recent earnings didn't contain any...